Financials

  • Market Capitalization 3.87 B
  • Employee 145
  • Founded 2015
  • CEO N/A
  • Website www.ideayabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00CTZ4D83
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-27.01
Relación precio/flujo de caja
13.99

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1518
TNGX
Tango Therapeutics, Inc. - Common Stock
23.34 USD-7.67%-1.10%-11.46%+253.10%3.94 B USD
1532
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
34.74 USD-6.56%-10.09%+76.43%+277.61%3.87 B USD
1541
DNLI
Denali Therapeutics Inc. - Common Stock
24.00 USD-2.72%-3.54%0.00%+48.42%3.84 B USD
1544
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.29 USD-0.79%-1.48%+12.45%+78.92%3.82 B USD

Noticias